We have put up a consortium of four partners from France, Italy, Germany and Spain to work on rare genetic microcytic hypochromic anemias due to defects in iron homeostasis or iron acquisition by erythroid precursors. The participants of this project have a long-standing interest in iron metabolism and related genetic disorders. The specific objectives of the project are 1. to recruit new patients with rare congenital microcytic anemias related to iron disorders in order to define new clinical entities, to delineate the clinical and biological phenotypes of these rare anemias and to provide therapeutical guidelines 2. to identify causative genes underlying the anemia by different strategies including sequencing of candidate genes, positional cloning or global siRNA screening. Thereby, we expect to discover new genes important for iron acquisition by erythroid cells. Combined with the previous clinical definitions, this will allow genotype/phenotype studies of these rare anemias 3. to perform functional studies on known candidate genes involved in rare inherited microcytic anemias, or on the newly identified genes, to improve our understanding of their role in iron metabolism.
Home ›
HMA-IRON
Submitted by josecobos on Wed, 2011-08-24 16:19
|
France
|
Germany
|
Italy
|
Spain
|
Project Coordinator
Carole Beaumont
INSERM U773
University Paris Diderot, Site Bichat
Paris
France
Partners
| Clara Camaschella |
IRCCS San Raffaele
Genetics and Biology
|
Milano | Italy |
| Maria del Carmen Sanchez |
Institut de Medicina Predictiva I Personalitzada des Cancer (IMPPC)
Genetics and Epigenetics of Cancer |
Barcelona | Spain |
| Martina Muckenthier |
Universitätsklinikum Heidelberd
Department of Pediatric Hematology, Oncology and Immunology |
Heidelberg | Germany |
Towards improved diagnosis and treatment of rare inherited microcytic hypochromic anemias related to iron metabolism
^ Back to Top
